APA (7th ed.) Citation

B, H., CL, Y., CY, W., CY, T., JJ, C., CC, H., . . . HY, Y. (2025). Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM. Scientific reports, 15(1), 12440. https://doi.org/10.1038/s41598-025-96996-3

Chicago Style (17th ed.) Citation

B, Huang, Yen CL, Wu CY, Tsai CY, Chen JJ, Hsiao CC, Chen YC, Hsieh IC, and Yang HY. "Author Correction: SGLT2 Inhibitors Reduce the Risk of Renal Failure in CKD Stage 5 Patients with Type 2 DM." Scientific Reports 15, no. 1 (2025): 12440. https://doi.org/10.1038/s41598-025-96996-3.

MLA (9th ed.) Citation

B, Huang, et al. "Author Correction: SGLT2 Inhibitors Reduce the Risk of Renal Failure in CKD Stage 5 Patients with Type 2 DM." Scientific Reports, vol. 15, no. 1, 2025, p. 12440, https://doi.org/10.1038/s41598-025-96996-3.